Pacientams, kurie neserga širdies ritmo ar laidumo sutrikimais.
REZULTATAI
C2HEST balas:
PV pasireiškimo rizika yra
Rekomendacijos:
Parengta remiantis:
2023 m. Amerikos kardiologų kolegijos prieširdžių virpėjimo gairėmis (Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation [Internet]. 2023 Nov 30;149(1). Available from: https://pubmed.ncbi.nlm.nih.gov/38033089/).
Haybar H, Shirbandi K, Rahim F. C2HEST score for atrial fibrillation risk prediction models: a Diagnostic Accuracy Tests meta-analysis. The Egyptian Heart Journal. 2021 Dec;73(1).
Li YG, Pastori D, Farcomeni A, Yang PS, Jang E, Joung B, et al. A Simple Clinical Risk Score (C2HEST) for Predicting Incident Atrial Fibrillation in Asian Subjects: Derivation in 471,446 Chinese Subjects, With Internal Validation and External Application in 451,199 Korean Subjects. Chest [Internet]. 2019 Mar 1 [cited 2023 Mar 7];155(3):510–8. Available from: https://www.sciencedirect.com/science/article/pii/S0012369218324929